Archives

  • Eton Pharmaceuticals Reports Positive Study Results for ET-101

    Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced positive

    Read More
  • Albumedix establishes new regulatory department following DMF acceptance

    Albumedix, a recombinant human albumin (rHA) specialist, has announced that the Center for Biologics Evaluation and Research (CBER), one of

    Read More
  • Biohaven Announces Patient Savings Program for the Acute Treatment of Migraine in Adults

    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced a Patient Savings Program for NURTEC™ ODT (rimegepant) that is now

    Read More
  • AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19

    AbCellera and Eli Lilly and Company (NYSE: LLY) announced today they have entered into an agreement to co-develop antibody products

    Read More
  • Covid-19 outbreak unlikely to impact credit rating of pharma companies

    The Covid-19 outbreak is unlikely to impact the credit profiles of India Ratings and Research (Ind-Ra) rated pharmaceutical companies in

    Read More

Archive

Offers